First Trust Direct Indexing’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,569
Closed -$255K – 668
2022
Q2
$255K Buy
1,569
+10
+0.6% +$1.58K 0.04% 521
2022
Q1
$293K Buy
1,559
+674
+76% +$128K 0.04% 514
2021
Q4
$234K Sell
885
-74
-8% -$19.9K 0.03% 563
2021
Q3
$277K Sell
959
-250
-21% -$64.1K 0.04% 501
2021
Q2
$241K Buy
1,209
+109
+10% +$21.1K 0.04% 518
2021
Q1
$214K Sell
1,100
-159
-13% -$32.6K 0.06% 366
2020
Q4
$241K Buy
+1,259
New +$229K 0.06% 328

Other funds holding RGEN

First Trust Direct Indexing's RGEN Position: Q3 2022 in Review

First Trust Direct Indexing sold out of Repligen (RGEN) in Q3 2022, closing a stake of 1,569 shares — an estimated $255K sold.

First Trust Direct Indexing first reported a position in RGEN in Q4 2020 and held it in 7 quarters. The position peaked at $293K in Q1 2022. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • First Trust Direct Indexing reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
  • First Trust Direct Indexing sold 1,569 Repligen shares in Q3 2022, an estimated $255K.
  • First Trust Direct Indexing first reported a position in Repligen in Q4 2020 and held it in 7 quarters.
  • First Trust Direct Indexing's Repligen position peaked at $293K in Q1 2022.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on First Trust Direct Indexing's 13F filing for Q3 2022, filed 27 Oct 2022.